Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

PHAP (NT) polyclonal antibody

ADI-905-233-100 100 µg 457.00 USD
Do you need bulk/larger quantities?

Product Details

Immunogen:Synthetic peptide corresponding to the sequence near the N-terminus of human PHAP.
UniProt ID:P39687
Species reactivity:Human, Mouse, Rat
Applications:IHC, WB
Recommended Dilutions/Conditions:Western Blot (0.5-2.0µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~28kDa by Western blot.
Purity Detail:Peptide affinity purified.
Formulation:Liquid. In PBS containing 0.02% sodium azide.
Shipping:Blue Ice Not Frozen
Long Term Storage:+4°C
Scientific Background:The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were identified as important regulators of mitochondrial mediated apoptosis. PHAP appears to facilitate apoptosome mediated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both ras- and myc mediated cell transformation.
Regulatory Status:RUO - Research Use Only
PHAP (NT) polyclonal antibody Immunocytochemistry
Immunocytochemistry analysis of PHAP in Raji cells with PHAP antibody at 1µg/ml.
PHAP (NT) polyclonal antibody Western blot
Western blot analysis of PHAP expression in human Raji cell lysate with PHAP antibody at 1µg/ml. The wide and strong band below PHAP III is a doublet composed of PHAP I (upper) and PHAP I2a (lower).
Please mouse over
PHAP (NT) polyclonal antibody Immunocytochemistry PHAP (NT) polyclonal antibody Western blot

Related Products

Goat anti-rabbit IgG, polyclonal antibody (HRP conjugate) 

ELISA, IHC, WB | Print as PDF
ADI-SAB-300-J 1 ml 150.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
PHAP Polyclonal antibody
By catalog section:


Technical Service
Customer Service